Bookmark

Add to MyYahoo RSS

Novartis News

News on Novartis (Ticker: NVS) continually updated from thousands of sources around the net.

15 hrs ago | Vision Monday

Alcon to Acquire WaveTec Vision, Developer of Intra-Operative Measurements for Cataract Surgery

Alcon , division of Novartis Group , announced this week that the company has entered into an agreement to acquire Aliso Viejo, Calif.-based WaveTec Vision , a privately-held company that developed the ORA System, the first commercialized intra-operative guidance system for cataract surgeons implanting intra-ocular lenses .

Comment?

Related Topix: Medicine, Surgery, Biotech, Aliso Viejo, CA

Wed Aug 20, 2014

BioSpace

Novartis AG, Global Alliance For TB Drug Development Link Up To Search For TB Cure

Novartis Provides Drug Candidate Compounds To TB Alliance Exclusive Worldwide License From Novartis Includes A Novel Class Of Drugs That Is Active Against Drug Sensitive And Multi-Resistant Strains Of Tuberculosis Basel, August 20, 2014 - Novartis has signed an exclusive worldwide licensing agreement with the Global Alliance for TB Drug Development ... (more)

Comment?

Related Topix: Biotech, Medicine, Malaria, Health

Tue Aug 19, 2014

TheStreet.com

Why Novartis (NVS) Stock Is Gaining Today

Under the agreement, Novartis would immediately invest $35 million in Gamida for the stake and receive an option to fully acquire the company, according to parent company Elbit Imaging STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months.

Comment?

Related Topix: Biotech, Financial Markets

Mon Aug 18, 2014

Bio IT World

Could Pharma Companies Succeed in the Digital Health Market?

Jason Bloomberg speaks to pharma executives and industry observers who believe top drug companies could soon focus more of their efforts on creating electronic health platforms, collecting user data and to more precisely define disease risks and personalize prevention and treatment.

Comment?

Related Topix: Biotech

BioSpace

Deal Is Back On: Novartis AG To Invest Heavily In Gamida Cell Ltd. Before Acquisition

The deal for the sale of Gamida Cell developer of a stem-cell treatment for blood cancer, to Novartis AG is back on.

Comment?

Related Topix: The Visionaire Group, Solve, Biotech, Novartis AG, Novartis, Medicine, Eons, Healthcare Industry

Wed Aug 13, 2014

Seeking Alpha

Drug Patent Expirations This Week: Pfizer's Nicotine Spray, Transdermal Hormones

One patent relates to Novartis/Noven/Novogyne's CombiPatch, as well as two other transdermal hormone therapies for postmenopausal women.

Comment?

Related Topix: Nicotine, NicoDerm, Nicotine (generic), Medicine, Pfizer, Biotech, Healthcare Industry, CombiPatch, Estradiol and Norethindrone Acetate (generic), Estradiol (generic), Climara, Estraderm, Marketing

BioSpace

Novartis AG, Siemens, And Laboratory Corporation of America Holdings...

Seventh Sense Biosystems Closes $16 Million Series B Financing CAMBRIDGE, Mass., Aug 13, 2014 -- Seventh Sense Biosystems, Inc. , the pioneering developer of virtually painless blood collection and diagnostic platforms, today announced a $16 million Series B financing from a syndicate of global leaders in diagnostic technologies, pharmaceuticals ... (more)

Comment?

Related Topix: Venture Capital, Emerging Technology, Biotech, Industrial Machines, Telecom, Siemens AG, Siemens, Medicine, Laboratory Corporation of America Holdings, Healthcare Industry, Cambridge, MA

Mon Aug 11, 2014

Seeking Alpha

Sunshine Heart C-Pulse: A Paradigm Shift In Heart Failure Therapy

Only Sunshine Heart's C-Pulse has achieved a significant reversal of Heart Failure in 60% of its FDA approved Feasibility Trial NYHA Class III and ambulatory Class IV heart failure patients.

Comment?

Related Topix: Heart Failure, Health, Lung Cancer, California Stem Cell, Biotech

Fibers.org

Partnership between Google and Novartis to create a 'smart' contact lens

'Smart' contact lenses that are capable of monitoring glucose levels in Diabetes sufferers, and potentially restoring the natural autofocus in people who wear glasses, could soon become a reality thanks to a partnership between Google and Novartis.

Comment?

Related Topix: Google, Startups, Emerging Technology, Search Engines, Biotech, Medicine, Diabetes, Health

Seeking Alpha

Sanofi Appears To Be In The Early Stages Of An Earnings Rebound

Sanofi , the subject of this article, is one of the oldest and largest pharmaceutical concerns in the world, competing in the same league as world-class enterprises Novartis , Pfizer , Glaxo , and Merck .

Comment?

Related Topix: Biotech, Medicine, SanofiSynthlabo, Genzyme General, Healthcare Industry, Pfizer, Merck

Wed Aug 06, 2014

IBM

Chosen to Manage Global SAP Infrastructure for Leading Swiss Healthcare Company

ZURICH / BASEL, Switzerland - 06 Aug 2014: IBM today announced that it signed a multi-year agreement with Novartis, one of the world's leading healthcare companies, to manage their global SAP infrastructure operations.

Comment?

Related Topix: Biotech, Novartis, Medicine, Healthcare Industry

Tue Aug 05, 2014

Seeking Alpha

Momenta Pharmaceuticals Heading For A Repeat

While most promising young biotechs devote all resources to development of new drugs, Momenta Pharmaceuticals is adopting a fairly unusual strategy of aiming for the middle.

Comment?

Related Topix: Medicine, Biotech, Momenta Pharmaceuticals, Teva Pharmaceutical Industries, Oncology

Fri Aug 01, 2014

BioSpace

Novartis AG Malaria Pill KAE609 Shows Promise As Best Drugs Fail

KAE609 is the first antimalarial drug candidate with a novel mechanism of action to achieve positive clinical proof-of-concept in over 20 years KAE609 was tested in adult patients with uncomplicated malaria and showed a median parasite clearance time of 12 hours, including in patients with resistant infections[1] For more than a decade, Novartis ... (more)

Comment?

Related Topix: Medicine, Malaria, Health, Biotech, Southeast Asia, World News, Thailand

Thu Jul 31, 2014

GuruFocus.com

Novartis: Ten Years of Solid ROE

In this article, letA s see one of the most important financial ratios applying to stockholders, the best measure of performance for a firm's management: the Return on Equity , and we are going to analyze it in the case of Novartis AG .

Comment?

Related Topix: Biotech

Seeking Alpha

Good Value Johnson & Johnson Could Outperform This Peer

In this article we're focusing on Johnson & Johnson and comparing it to a similar sized rival in Novartis .

Comment?

Related Topix: Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Financial Markets

MarketNewsVideo

VGK, GULF: Big ETF Outflows

Looking at units outstanding versus one week prior within the universe of ETFs covered at ETF Channel, the biggest outflow was seen in the Vanguard FTSE Europe ETF , where 2,699,946 units were destroyed, or a 1.0% decrease week over week.

Comment?

Related Topix: Biotech, Video, Business News

Wed Jul 30, 2014

Seeking Alpha

Novartis: The Case Of The Undervalued Biosimilar Pioneer

Most investors, specially when they start looking at this sector, find themselves overwhelmed with information and technical jargon.

Comment?

Related Topix: Biotech, Novartis, Medicine, Healthcare Industry, Teva Pharmaceutical Industries, Hispanic Broadcasting, Television, Amgen

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••